Skip to content
  • Sunday, 23 August 2026
  • 1:06 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 23, 2026 0

The landscape of generic drug economics in the United States is undergoing a significant transformation, largely driven by the advent…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 15, 2026 0

The United States, long an outlier in global pharmaceutical pricing, is undergoing a profound transformation in its drug cost landscape,…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 8, 2026 0

The U.S. pharmaceutical landscape, historically characterized by higher drug prices compared to other developed nations, is undergoing a significant transformation,…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jul 4, 2026 0

In a landmark decision poised to reshape access to one of the world’s most sought-after medications, Health Canada has granted…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jun 30, 2026 0

The United States healthcare system, grappling with persistently high drug costs, has seen significant shifts in its economic landscape, particularly…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jun 26, 2026 0

In a landmark decision poised to reshape access to one of the world’s most in-demand medications, Health Canada has granted…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jun 18, 2026 0

The pharmaceutical landscape for diabetes and weight management medications has undergone a significant shift with Health Canada’s authorization of Dr.…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha May 21, 2026 0

The Canadian healthcare landscape is poised for a significant transformation with Health Canada’s authorization of Dr. Reddy’s Laboratories’ generic semaglutide…

Read More
Guardrails for LLMs: Measuring AI ‘Hallucination’ and VerbosityBeyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity marketLilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ